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Abstract  
BACKGROUND  
According to epidemiological reports, soybean has been proposed to reduce the risk of 
cerebral infarctions. However, it is unknown whether miso can reduce the incidence of 
stroke in animal models. In this study, we investigated the effects of soybean paste 
(miso) in an animal model of stroke.  
METHODS  
Stroke-prone spontaneously hypertensive rats (SHRSP) were fed a miso diet (normal 
diet 90%, miso 10%; final NaCl content 2.8%), a high salt diet (normal diet and NaCl 
2.5%; final NaCl content 2.8%), or a low salt diet (normal diet only; final NaCl content 
0.3%).  
RESULTS  
Survival in the high salt group was significantly lower than in the miso and low salt 
groups (p<0.01). Large hemorrhagic macules were found in the cerebrum in the high 
salt group, whereas none were found in the other two groups. There were also fewer 
histological and immunohistochemical changes in the brain and kidneys in the miso 
group compared to the high salt group.  
CONCLUSIONS  
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Our results suggest that miso may have protective effects against stroke despite its high 
salt content. 
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INTRODUCTION 
Miso is a traditional Japanese food fermented from soybeans. It is used regularly 
as a flavoring in soup and is an essential ingredient in Japanese-style cooking. We 
previously reported that miso can suppress the development of liver tumors, gastric 
tumors, lung tumors, and aberrant crypt foci (ACF) and colon tumors in mice and rats1. 
We also reported that miso can prevent the induction of hypertension in Dahl salt 
sensitive hypertensive rats despite its high salt content2. These findings were further 
supported by similar studies conducted by Yoshinaga et al.3  
Kokubo et al.4 reported an inverse association between isoflavone intake and 
risk of cerebral and myocardial infarctions in Japanese women. In this context, we 
thought that it would be interesting to examine the association between brain infarction 
and nutrition; more specifically, whether administration of miso can reduce the 
incidence of stroke in animal models. Stroke-prone spontaneously hypertensive rats 
(SHRSP) are generated from spontaneously hypertensive rats (SHR)5-11, and excessive 
salt intake in this model increases the rate of fatal strokes. Sepehrdad et al.9 reported 
that all SHRSP provided with a 1% NaCl drinking solution died by 16.4 weeks. 
Camargo et al.10 reported that survival of SHRSP at 12 weeks was 26% in the 4% NaCl 
diet group and Kim-Mitsuyama et al.11 reported that all SHRSP died by 42 days when 
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provided a 8% NaCl diet. In this study, we examined the effects of miso intake on the 
incidence of stroke in SHRSP.  
    
MATERIALS AND METHODS 
This study was carried out in accordance with guidelines of the Institute of 
Laboratory Animal Science, Hiroshima University. The experimental protocols were 
approved by the ethics committee on animal experiments of Hiroshima University 
(Permission Number: A-14-114). 
A total of 36 4-week-old male SHRSP (SHRSP/Izm) were purchased from 
Nihon SLC, Ltd. (Hamamatsu, Japan) and divided into three groups: low salt diet 
(normal diet, Oriental Yeast Co., Tokyo, Japan; final NaCl content 0.3%), miso diet 
(normal diet 90% and miso 10%; final NaCl content 2.8%), and high salt diet (normal 
diet supplemented with 2.5% NaCl; final NaCl content 2.8%). We used red rice miso, 
which was fermented for 180 days and freeze-dried by the supplier (Miyasaka Jozo Co. 
Ltd., Tokyo, Japan).  
Rats were maintained as previously reported2. Normal tap water was provided 
ad libitum. Animals were observed three times per day and autopsied under ether 
anesthesia if they showed ataxic movements, were motionless, or were moribund. 
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Animals alive at the end of experiment (63 days) were examined under ether anesthesia. 
Animal weight and food and water intake were measured. 
Blood pressure was measured at 14, 28, and 42 days after initiation of the 
specific diets using the tail-cuff method (BP-98E, Softron Co. Ltd., Tokyo)9. Bodies and 
major organs were weighed and fixed in phosphate-buffered 3% formalin. Histological 
evaluation was performed by routine procedures with H&E, periodic acid-Schiff 
(PAS)-Alcian blue, and Azan-Mallory staining. 
Using a cross-section containing the cerebral cortex, thalamus, third ventricle, 
and hippocampus at level II, as described by Solleld et al.12, we examined all arteries 
(A) and veins (V) on the surface (S) of the brain and referred to them as A-S and V-S, 
respectively. Similarly, arteries and veins inside (I) the brain were examined and 
referred to as A-I and V-I, respectively. Vessels in each classification (A-S, V-S, A-I, and 
V-I) were scored as zero or one. When no thrombus was observed, the score was zero. If 
one or more thrombi were identified, a score of one was assigned. The scores of the four 
classifications were summed to generate a total score (minimum, 0; maximum, 4), and 
the mean total score ± SD was calculated for each group.  
Kidney sections (3-µm thick) were treated for 30 min at room temperature with 
2% BSA and incubated with primary antibodies against CD68 (diluted 1:200; Serotec 
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MCA341R), and monoclonal mouse anti-α smooth muscle antigen (αSMA, dilute 
1:1000, Sigma-Aldrich A2547) antibodies overnight at 4℃. Serial sections were used for 
negative controls (no primary antibody). All slides were exposed to a biotinylated 
secondary antibody and streptavidin-peroxidase using the Ultra Tech HRP kit (Ultra 
Tech HRP PN IM2391). Peroxidase activity was visualized by treatment with H2O2 and 
diaminobenzidine for 30 min. At the final step, αSMA-stained sections were 
counterstained with PAS. CD68-positive cells were counted per 10 sites at 200x 
magnification, and αSMA-positive areas were measured using an image analyzer (Win 
Roof, Mitani Co, Fukui Japan). 
Statistical significance was determined with Dunnett's method, multiple linear 
regression, Cox proportional hazards model, and the χ2-test. 
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RESULTS 
Body weight 
Body weight at 56 days after initiation of the diets did not differ between the 
three groups (Supplementary Table 1). 
     
Intake of water and food  
After initiation of the diets, the amount of drinking water and food consumed by 
each group were measured for 56 days and mean values were calculated as 
ml/animal/day or gram/animal/day, respectively. Water consumption in the high salt 
group (42.6±7.4 ml/animal/day) was significantly higher than in the miso group 
(38.3±4.7 ml/animal/day), which was greater than in the low salt group (29.8±4.4 
ml/animal/day). There were no significant differences in amount of food consumed 
between groups (Supplementary Table 2). 
    
Blood pressure 
At 28 days after the initiation of diets, systolic blood pressure (SBP) in the high 
salt group was significantly increased (p<0.01) compared to the miso and low salt 
groups. This difference was maintained until 42 days (p<0.05, Figure 1A). Although 
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diastolic blood pressure (DBP) was significantly increased in both miso and high salt 
groups at 14 days (p<0.05), only the high salt group showed significantly higher DBP at 
42 days (p<0.05). 
 
 
Animal survival 
 
Of the 36 total rats, we observed 18 events of paralysis and one death. Rats were 
autopsied immediately after these events. None of the rats in the high salt group 
survived for 64 days, while survival was noted for seven (64%) in the miso group and 
10 (83%) in the low salt group (Supplementary Table 3). The Cox proportional hazards 
model revealed that event-free time was significantly shorter only in the high salt group 
(p=0.0008, Figure 1B). 
 
 
Histological findings in the brain 
 
Macroscopically, large hemorrhagic macules were observed on the surface of the 
cerebrum in six of 12 rats in the high salt group (Figure 2Aa), whereas no macules were 
observed in the miso and low salt groups (p<0.01, Figure 2B). After macroscopic 
inspection, brains were sectioned at the caudal border of the mammillary body for 
microscopic analysis12. Small hemorrhagic sites were observed in both the miso and 
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high salt groups (Figure 2Ab), with no significant difference in the number of sites 
between the two groups (Figure 2B). 
Thrombi were frequently observed in cerebral arteries and veins in the high salt 
group (Figure 2Cc). The thrombus score significantly differed between the three groups 
(low salt, 1.92±1.00; miso, 2.23±0.90; high salt, 3.25±1.06; Figure 2D).  
 
Biochemical markers 
Supplementary Table 3 summarizes the biochemical parameters of the three 
groups. Blood glucose and total cholesterol levels in the miso and high salt groups were 
significantly increased compared to the low salt group. Conversely, total protein, 
albumin, ALP, Na, and Cl levels were lower in the miso and high salt groups compared 
to the low salt group. It is noteworthy that creatinine and BUN in the high salt group 
was significantly higher than in the miso and low salt groups. 
  
Histological findings in kidneys   
Protein casts and thickened adventitia of arteries were increased in the miso and 
high salt groups compared to the low salt group (Figure 3A), while the number of 
degenerated glomeruli was only increased in the high salt group (Supplementary Table 
Watanabe et al 12   
 
 
4). Area of collagen fibers was also significantly larger in the high salt group compared 
to the other two groups. Pale staining of columnar epithelium of renal tubules was 
detected in all groups (Figure 3A). 
The numbers of CD68-positive cells and αSMA-positive areas, both of which 
are markers of kidney damage, were decreased in the miso group compared to the high 
salt group (Figures 3B and 3C). 
 
DISCUSSION 
The findings of the present study suggest that miso can suppress the incidence of 
stroke and injuries to the brain and kidneys in a rat model of stroke relative to high salt 
intake conditions. Alderman et al. proposed an interesting paradox that amongst people 
with high sodium consumption, Japanese people have a longer lifespan13. Anderson et al. 
showed that, when comparing Japan, the United States, the United Kingdom, and China, 
people in Japan had the highest sodium intake, of which approximately 30% was from 
fermented foods such as miso and soy sauce; however, blood pressure was the lowest in 
Japan14. We previously reported that miso has potent anti-hypertensive effects in Dahl 
salt sensitive hypertensive rats2. In that study, the difference in blood pressure between 
the miso group and high salt group was substantial and reached 35 mmHg. Here, we 
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found that miso also has anti-hypertensive effects in a different model of hypertension. 
However, the effects of miso were somewhat weaker in this model, with a difference in 
blood pressure of only about 10 mmHg between the miso and high salt groups. 
Yamori et al. reported that inclusion of supplemental proteins such as fish or 
soybean protein, calcium, potassium, magnesium, and fiber in food can effectively 
prevent stroke in SHRSP7. Although the anti-hypertensive effect of miso was not so 
remarkable in SHRSP, miso clearly reduced the incidence of fatal stroke, suggesting 
that miso components may have a direct effect on stroke prevention. 
Isoflavones found in soybeans are known to have cholesterol-lowering effects16. 
Liu et al. reported in a meta-analysis of 11 randomized controlled trials that ingestion of 
65-153 mg of soy isoflavones per day lowered blood pressure in hypertensive subjects17. 
Furthermore, Kokubo et al. reported an inverse association between dietary intake of 
isoflavones, miso, and beans and cerebral and myocardial infarctions in Japanese 
women without cardiovascular disease4. Given that miso contains a lower amount of 
isoflavones than beans (Nakano K, Central Miso Institute, Tokyo, Japan, personal 
communication), isoflavones may play a minor role in the anti-stroke effects of miso. 
We recently found that the levels of 25 substances, including genistein, several 
anti-hypertensive substances, anti-diabetic substances, and some antioxidants, increase 
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during the fermentation/maturation of miso (unpublished data). This raises the 
possibility that miso may contain compounds that are directly protective against stroke. 
Further studies will be needed to identify the effective factors in miso that confer 
protection against stroke and to elucidate the mechanisms underlying this effect. 
In conclusion, our findings suggest that a miso-containing diet, regardless of its 
high salt content, may be protective against stroke.  
   
Source of Funding 
This work was supported by a grant-in-aid from the Central Miso Institute, 
Tokyo, Japan. 
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FIGURE LEGENDS 
Figure 1. Blood pressure and event-free survival of rats 
A. Mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) in SHRSP. 
Data are presented as mean±SD. Animals were given a low salt diet (0.3%NaCl), a miso 
diet (2.8% NaCl), or a high salt diet (2.8% NaCl) for the indicated durations. 
*Significantly different from low salt group (p<0.05), ** Significantly different from 
low salt group (p<0.01), § Significantly different from miso group (p<0.05), 
†Significantly different from miso group (p<0.01). 
B. Event-free survival in the low salt (●), miso (△), and high salt (■) groups, as assessed 
by Cox proportional hazards model analysis. Life span of the high salt group was 
significantly shorter (P=0.0008) compared to the miso and low salt groups. 
 
Figure 2. Macroscopic and microscopic analysis of brain 
A. Bleeding in the brain (macroscopic (2Aa) and microscopic (2Ab)). 
B. Incidence of bleeding in the brain (by macroscopic and microscopic observations). In 
the high salt group, the number of large hemorrhagic macules in the brain was 
significantly higher than that in the miso and low salt groups. 
C. Microscopic analysis of arteries and veins on the surface of the brain in the low salt 
(2Ca), miso (2Cb), and high salt (2Cc) groups. Thrombi in arteries and veins on the 
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surface of brain are indicated by arrows (2Cc). The bar indicates 100 μm. 
D. Thrombus scores for all vessels in the brain. Dots (●) indicate the score of each 
animal. At the bottom of the figure, scores for each group are expressed as mean±SD. 
** Significantly different from low salt group (p<0.01), * Significantly different from 
miso group (p<0.05). 
 
Figure 3. Microscopic and immunohistological analysis of kidneys 
A. Histological examination of kidneys in the low salt (3Aa), miso (3Ab), and high salt 
(3Ac) groups. Pale staining columnar epithelium (arrows), protein cast in renal cortex 
(P), degeneration of glomeruli (D), and thickening of adventitia of arteries (T). Bar 
indicates 100 μm, Azan Mallory staining. 
B. Number of CD68-positive cells in the kidney cortex. Cell number per one 
microscopic field under 200x magnification was counted and expressed as mean±SD for 
each group. 
C. αSMA-positive areas in the kidney cortex. αSMA-positive areas per field (200x 
magnification) were measured and expressed as mean±SD (μm2) for each group.    
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SUPPLEMENTAL DATA 
Supplementary Table 1. Body weight (g) 
Days Low salt Miso High salt 
0 67.0±3.1 (12) 66.9±3.7 (12) 63.4±4.6 (12) 
    
14 145.5±5.5 (12) 142.8±6.0 (12) 142.6±5.9 (12) 
    
28 207.3±8.6 (12) 207.6±11.0 (12) 215.2±9.3 (12) 
    
42 237.1±11.7 (12) 238.6±13.0 (12) 243.5±9.5 (12) 
    
56 254.8±14.4 (12) 243.3±37.2 (10) 234.50±28.4 (12) 
    
58 NA NA 232.7±16.5 (6) 
    
63 257.2±28.4 (10) 232.7±36.6* (6) NA 
Data are presented as mean±SD 
( ) Number of animals 
* Significantly different from 63 days in low salt group (p<0.05) 
 
 
Supplemental Data
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Supplementary Table 2. Water and food intake 
 Low salt Miso High salt 
Drinking water 
(ml/animal/day) 
29.8±4.4 38.3±4.7** 42.6±7.4**,§ 
 
Food 
(g/animal/day) 
 
15.7±0.6 
 
15.7±0.8 
 
16.3±1.2 
Data are presented as mean±SD 
** Significantly different from low salt group (p<0.01) 
 § Significantly different from miso group (p<0.01) 
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Supplementary Table 3. Number of surviving rats 64 days after treatment 
 
Group Total animals Surviving animals 
Low salt 12 10 (83%) 
Miso 11 7 (64%) 
High salt 12 0* (0%) 
* Significantly different from low salt and miso groups (p<0.05) 
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Supplementary Table 4. Biochemical markers  
 Low salt Miso High salt 
Total protein (g/dl) 6.61±0.27 6.17±0.42** 6.19±0.45** 
Albumin (g/dl) 4.58±0.26 4.19±0.30** 4.15±0.28** 
A/G ratio 2.30±0.30 2.16±0.31 2.06±0.27* 
Blood glucose (mg/dl) 174.5±40.7 267.3±132.5* 241.4±67.7* 
TG (mg/dl) 110.3±61.6 95.9±29.6 127.2±61.1 
Total cholesterol (mg/dl) 74.6±15.4 93.6±19.7* 114.1±26.2**, § 
HDL cholesterol (mg/dl) 34.9±2.7 38.4±7.6 41.6±8.4* 
LDL cholesterol (mg/dl) 4.25±1.96 5.21±1.85 8.78±5.46**, § 
AST (U/L) 924.0±294.3 593.1±285.1 493.0±155.2 
ALT (U/L) 56.5±11.3 51.6±16.7 51.9±22.8 
LDH (U/L) 683.0±406.2 595.4±285.5 626.2±348.9 
ALP (U/L) 924.0±294.3 593.1±285.1** 493.0±155.2** 
γ-GTP (U/L) 1.50±0.52 1.79±0.58 1.78±0.55 
Choline esterase (U/L) 4.42±1.56 5.07±2.30 5.17±1.98 
Amylase (U/L) 1005.5±284.4 1040.6±438.4 967.2±147.9 
Creatinine (mg/dl) 0.22±0.05 0.25±0.08 0.28±0.04** 
Uric acid (mg/dl) 2.00±1.11 2.51±1.06 3.33±2.89 
BUN (mg/dl) 21.8±6.3 25.9±6.4 26.0±3.8* 
Na (mEq/L) 143.1±3.3 138.6±7.0* 138.4±5.6* 
K (mEq/L) 3.49±0.35 3.59±1.08 3.43±0.62 
Cl (mEq/L) 99.6±3.6 93.9±6.7* 92.9±5.4** 
Data are presented as mean±SD 
* Significantly different from low salt group (p<0.05) 
** Significantly different from low salt group (p<0.01) 
§ Significantly different from miso group (p<0.05)  
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Supplementary Table 5. Kidney histology 
 Low salt Miso High salt 
Pale staining columnar 
epithelium  
12/12 (100) 10/10 (100) 12/12 (100) 
    
Protein cast  6/12 (50) 10/10 (100) 12/12 (100) 
    
Number of animals with 
glomerular degeneration  
1.8±0.5 2.6±1.7 5.5±1.2*,§ 
    
Thickened adventitia in kidney 
arteries 
 
Area of collagen fiber cortex 
(µm2) 
4/12 (33) 
 
 
88176±2294 
10/10 (100) 
 
 
104016±8464** 
12/12 (100) 
 
 
141641±4831**,.§ 
Data are presented as mean±SD 
* Significantly different from low salt group (p<0.05) 
** Significantly different from low salt group (p<0.01) 
§ Significantly different from miso group (p<0.05)  
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